OTW

BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter

Retrieved on: 
Thursday, February 8, 2024

BUELACH, Switzerland, Feb. 8, 2024 /PRNewswire/ -- BIOTRONIK is proud to introduce the Micro Rx™ catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI). This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions). Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.

Key Points: 
  • This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions).
  • Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.
  • The Micro Rx catheter is commercially available today in the United States and in March 2024 in Canada.
  • "IMDS has invested its expertise and dedication into the development of the Micro Rx catheter, with a specific focus on alleviating challenges in PCI," said Ryan Walters, President at BIOTRONIK USA.

This Week in Consumer News: 14 Stories You Need to See

Retrieved on: 
Friday, June 23, 2023

NEW YORK, June 23, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the consumer and retail industries stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • These are just a few of the recent press releases that consumers and the media should know about.
  • To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists .
  • Subject Matter Experts: Access ProfNet , a database of industry experts to connect with as sources or for quotes in your articles.
  • Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines , for media news roundups, writing tips, upcoming events, and more.

Vans Announces New Pinnacle Category: OTW by Vans

Retrieved on: 
Wednesday, June 21, 2023

OTW by Vans is a new vision for the most pinnacle expression of Vans, conceived under the direction of Ian Ginoza, Vice President, Creative Direction for Pinnacle.

Key Points: 
  • OTW by Vans is a new vision for the most pinnacle expression of Vans, conceived under the direction of Ian Ginoza, Vice President, Creative Direction for Pinnacle.
  • A platform for pushing boundaries and challenging conventions, OTW by Vans channels its skateboarding origins to drive a distinct and unique point of view.
  • "We are rooting the next chapter of Vans in the attitude and mindset of the brand's true self, defined and shaped by the community of original disruptors.
  • OTW by Vans is a reorientation back to who we truly are... back to 'Off The Wall'."

Vans Announces New Pinnacle Category: OTW by Vans

Retrieved on: 
Wednesday, June 21, 2023

OTW by Vans is a new vision for the most pinnacle expression of Vans, conceived under the direction of Ian Ginoza, Vice President, Creative Direction for Pinnacle.

Key Points: 
  • OTW by Vans is a new vision for the most pinnacle expression of Vans, conceived under the direction of Ian Ginoza, Vice President, Creative Direction for Pinnacle.
  • A platform for pushing boundaries and challenging conventions, OTW by Vans channels its skateboarding origins to drive a distinct and unique point of view.
  • "We are rooting the next chapter of Vans in the attitude and mindset of the brand's true self, defined and shaped by the community of original disruptors.
  • OTW by Vans is a reorientation back to who we truly are... back to 'Off The Wall'."

FDA Clears Angioplasty Platform to Crack, Break, and Dilate Stenosis in Calcified Cardiovascular Disease and Hemodialysis Fistula

Retrieved on: 
Thursday, October 27, 2022

SALT LAKE CITY, Oct. 27, 2022 /PRNewswire/ -- Transit Scientific, a pioneer in developing medical devices to treat calcified cardiovascular disease, dilate stenosed intimal hyperplasia, and access, cross, & deliver to distal vessels, announced today the XO RX 2.2F and XO RX 3.8F Platform received FDA clearance to crack, break, and dilate stenoses in peripheral arteries and arteriovenous dialysis fistula associated lesions.

Key Points: 
  • "The new 3.8F XO RX has a low profile and accommodates 20 cm balloons making it a good option for PAD and CLI disease.
  • The lower profile 2F version helps address gaps in treatment options currently available for BTK, tibiopedal, and pedal loop stenoses."
  • XO RX and XO OTW (over-the-wire) exoskeleton devices include up to (22) rotating struts that slide onto a broad range of off-the-shelf angioplasty balloons.
  • "Patients and clinicians need more tools to crack, break, and dilate occlusive lesions in patients with cardiovascular disease.

OpenText World 2022 set to Deliver the Ultimate Information Management Experience

Retrieved on: 
Thursday, September 22, 2022

WATERLOO, ON, Sept. 22, 2022 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX) today announced the programming highlights for the world's largest information management conference, OpenText World 2022, being offered in-person and virtually. Registration is now open for the three-day interactive event being hosted live from The Venetian Hotel Resort Las Vegas from October 4–6.

Key Points: 
  • WATERLOO, ON, Sept. 22, 2022 /PRNewswire/ -- OpenText (NASDAQ: OTEX), (TSX: OTEX) today announced the programming highlights for the world's largest information management conference, OpenText World 2022, being offered in-person and virtually.
  • OpenText World 2022 brings together the brightest minds in information management, leading technology experts, exciting guest speakers, industry professionals, and strategic partners to showcase how information is driving change.
  • In his keynote, OpenText CEO & CTO Mark J. Barrenechea will explore the state of the industry across the globe, the future of information management, and the path to information advantage.
  • OpenText, The Information Company, enables organizations to gain insight through market leading information management solutions, powered by OpenText Cloud Editions.

Northeast Scientific Inc. wins 510(k) for Turbo-Elite Laser Atherectomy Catheter reprocessing

Retrieved on: 
Tuesday, July 26, 2022

WATERBURY, Conn., July 26, 2022 (GLOBE NEWSWIRE) -- Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA clearance for reprocessing the Philips Spectranetics 0.9mm OTW Turbo-Elite laser atherectomy catheter.

Key Points: 
  • WATERBURY, Conn., July 26, 2022 (GLOBE NEWSWIRE) -- Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA clearance for reprocessing the Philips Spectranetics 0.9mm OTW Turbo-Elite laser atherectomy catheter.
  • This is yet another first of its kind accomplishment for the Connecticut based company, as this is the first time the FDA has awarded a 510(k) clearance for reprocessing this type of atherectomy catheter.
  • The company has said that it will have an additional announcement soon regarding when the 0.9mm OTW Turbo-Elite laser atherectomy catheter device will be available for sale.
  • With an unparalleled record for quality and safety across their 15 years of business, Northeast Scientific has reprocessed over 650,000 devices.

OpenText Powers the Information Advantage with Cloud Editions 22.2

Retrieved on: 
Tuesday, June 21, 2022

WATERLOO, ON, June 21, 2022 /PRNewswire/ -- Today at OpenText World EMEA, OpenText™ (NASDAQ: OTEX), (TSX: OTEX), announced Cloud Editions 22.2 (CE 22.2) featuring new capabilities and innovations that enable businesses to be agile, responsive, and resilient in a time when disruption is accelerating. As a global leader in information management, OpenText is powering and protecting businesses to achieve the information advantage by being intelligent, connected, and responsible.

Key Points: 
  • As a global leader in information management, OpenText is powering and protecting businesses to achieve the information advantage by being intelligent, connected, and responsible.
  • This enables businesses to accelerate information flows, ensure timely and accurate information enters NetSuite and future-proof digital processes.
  • Organizations can turn information into an advantage by connecting people with the information and tools they use every day for richer, personalized experiences.
  • OpenText, The Information Company, enables organizations to gain insight through market leading information management solutions, powered by OpenText Cloud Editions.

S.M.A.R.T. RADIANZ™ Vascular Stent System Approved for Transradial Use in the U.S.

Retrieved on: 
Thursday, March 10, 2022

RADIANZ Vascular Stent System, a self-expanding stent purposefully engineered for radial peripheral procedures.

Key Points: 
  • RADIANZ Vascular Stent System, a self-expanding stent purposefully engineered for radial peripheral procedures.
  • RADIANZ Vascular Stent System facilitates accurate, efficient placement of stents in the iliac and superficial femoral (SFA) arteries.
  • The newly approved vascular stent system joins the BRITE TIP RADIANZ Guiding Sheath and SABERX RADIANZ PTA Catheter to complete the RADIANZ Radial Peripheral System, specifically designed to optimize radial access, deliver exceptional outcomes, and high levels of patient satisfaction.
  • RADIANZ Vascular Stent Systemfeatures improved ergonomics and advanced one-handed deployment capability, offering excellent placement accuracy and up to 300% greater stability.

Opmantek Onboards Experienced Marketing Leader Chris Jacko as General Manager Marketing

Retrieved on: 
Thursday, November 18, 2021

Opmantek Software , one of the worlds leading providers of automated network management software, has appointed Chris Jacko as General Manager Marketing, joining the company in October 2021.

Key Points: 
  • Opmantek Software , one of the worlds leading providers of automated network management software, has appointed Chris Jacko as General Manager Marketing, joining the company in October 2021.
  • We are thrilled to have a professional of Chris caliber and experience join the Opmantek executive team to support our continued growth and development, said CEO Craig Nelson.
  • Im excited to be joining the Opmantek executive team at such a pivotal moment in the companys history, said Jacko.
  • Opmantek is an industry-leading software company operating in the field of Intelligent Network Management, Network Process Automation and IT Audit.